Xeris Biopharma up over 27%, on Track for Highest Close Since February 2019

Dow Jones11-06

Xeris Biopharma Holdings, Inc. $(XERS)$ is currently at $13.33, up $2.87 or 27.44%

--Would be highest close since Feb. 11, 2019, when it closed at $14.70

--On pace for largest percent increase since May 16, 2022, when it rose 29.24%

--Currently up three consecutive days; up 31.07% over this period

--Best three day stretch since the three days ending Aug. 11, 2025, when it rose 31.15%

--Up 69.81% year-to-date

--Down 51.05% from its all-time closing high of $27.23 on Sept. 10, 2018

--Up 72.89% from 52 weeks ago (Nov. 6, 2025), when it closed at $7.71

--Would be a new 52-week closing high

--Up 151.98% from its 52-week closing low of $5.29 on March 24, 2026

--Traded as high as $13.74; highest intraday level since Feb. 11, 2019, when it hit $15.00

--Up 31.36% at today's intraday high; largest intraday percent increase since May 16, 2022, when it rose as much as 32.75%

All data as of 11:00:46 AM ET

Source: Dow Jones Market Data, FactSet

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment